Through both loss-of-function (siRNA-based knockdown) and gain-of-function (ectopic overexpression) assays, we found that IGF2BP2 is a positive regulator of proliferation, colonic survival, and migration in lung cancer cells both in in vitro and in vivo. This evidence concerns the gene IGF2BP2 and lung carcinoma.